Allergic reactions doom factor IXa inhibitor and antidote
Leading cardiologist picks studies with most impact
Aggressive intervention fails to improve outcomes
Data gives no reason for changes in clinical practice
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A feasible option for high-risk patients
Unprecedented LDL-C reductions raise hopes for long-term outcome trials
Systems will share clinical, academic and research components
Is the gut microbiome the body’s largest endocrine organ?
The third pathway for arterial revascularization
Here’s where this state-of-the-art treatment stands
Advertisement
Advertisement